Every second, millions of cells in your body divide — and a lot can go wrong. Researchers from the University of Zurich and Spain's National Cancer Research Centre (CNIO) have discovered that cohesin, a protein already known for organizing DNA inside the nucleus, plays a critical new role: acting as a molecular first responder when DNA replication hits a snag.

When the replication machinery stalls — say, because the cell runs low on building blocks — cohesin rapidly moves to the trouble spot. It stabilizes the DNA structure and suppresses a backup repair factor called Primpol, which can restart replication but at the cost of introducing a flood of genetic errors. By doing both, cohesin keeps the genome intact.

Key Takeaways:

• Cohesin is mutated in several cancers, including Ewing sarcoma, bladder cancer, and some myeloid leukemias — making this discovery clinically relevant
• Many cancer treatments work by inducing replication stress; understanding cohesin's protective role could help design combination therapies that selectively disable it in tumor cells while sparing healthy ones
• A new genomic method developed for this study maps the 3D organization of newly replicated DNA, offering a powerful tool for future research

Why it matters: This discovery reframes how we understand genome stability and could guide the next generation of precision oncology strategies — potentially making cancer treatments more effective while reducing toxicity.